Updating PET/CT performance standards and PET/CT interpretation criteria should go hand in hand

by Ronald Boellaard, Terez Sera, Andres Kaalep, Otto S. Hoekstra, Sally F. Barrington, Josée M. Zijlstra
Published 2019-10-01

Conditional relative survival among patients with nodular lymphocyte-predominant Hodgkin lymphoma in the Netherlands

by Hidde L. A. Posthuma, Josée M. Zijlstra, Otto Visser, Marie José Kersten, Pieternella J. Lugtenburg, Avinash G. Dinmohamed
Published 2021-05-01

Performance of 89Zr-Labeled-Rituximab-PET as an Imaging Biomarker to Assess CD20 Targeting: A Pilot Study in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma.

by Yvonne W S Jauw, Josée M Zijlstra, Daphne de Jong, Danielle J Vugts, Sonja Zweegman, Otto S Hoekstra, Guus A M S van Dongen, Marc C Huisman
Published 2017-01-01

Potential and pitfalls of 89Zr-immuno-PET to assess target status: 89Zr-trastuzumab as an example

by Marc C. Huisman, C. Willemien Menke-van der Houven van Oordt, Josée M. Zijlstra, Otto S. Hoekstra, Ronald Boellaard, Guus A. M. S. van Dongen, Dhaval K. Shah, Yvonne W. S. Jauw
Published 2021-08-01

Immuno-positron emission tomography with zirconium-89-labeled monoclonal antibodies in oncology

by Yvonne W.S. Jauw, C. Willemien Menke-van der Houwen van Oordt, Otto S. Hoekstra, N. Harry Hendrikse, Danielle J. Vugts, Josee M. Zijlstra, Marc C. Huisman, Guus A.M.S. van Dongen
Published 2016-05-01

Efficacy and cost-utility of the eHealth application ‘Oncokompas’, supporting patients with incurable cancer in finding optimal palliative care, tailored to their quality of life a...

by Anouk S. Schuit, Karen Holtmaat, Nienke Hooghiemstra, Femke Jansen, Birgit I. Lissenberg-Witte, Veerle M. H. Coupé, Myra E. van Linde, Annemarie Becker-Commissaris, Jaap C. Reijneveld, Josée M. Zijlstra, Dirkje W. Sommeijer, Simone E. J. Eerenstein, Irma M. Verdonck-de Leeuw
Published 2019-10-01

Reduced-Intensity Chemotherapy in Patients With Advanced-Stage Hodgkin Lymphoma

by Andreas Engert, Helen Goergen, Jana Markova, Thomas Pabst, Julia Meissner, Josée M. Zijlstra, Zdenek Král, Dennis A. Eichenauer, Martin Soekler, Richard Greil, Stefanie Kreissl, Ruth Scheuvens, Hans Eich, Carsten Kobe, Markus Dietlein, Harald Stein, Michael Fuchs, Volker Diehl, Peter Borchmann
Published 2017-12-01

Survival among patients with relapsed/refractory diffuse large B cell lymphoma treated with single-agent selinexor in the SADAL study

by Marie Maerevoet, Josee M. Zijlstra, George Follows, Rene-Olivier Casasnovas, J. S. P. Vermaat, Nagesh Kalakonda, Andre Goy, Sylvain Choquet, Eric Van Den Neste, Brian Hill, Catherine Thieblemont, Federica Cavallo, Fatima De la Cruz, John Kuruvilla, Nada Hamad, Ulrich Jaeger, Paolo Caimi, Ronit Gurion, Krzysztof Warzocha, Sameer Bakhshi, Juan-Manuel Sancho, Michael Schuster, Miklos Egyed, Fritz Offner, Theodoros P. Vassilakopoulos, Priyanka Samal, Matthew Ku, Xiwen Ma, Kelly Corona, Kamal Chamoun, Jatin Shah, Sharon Shacham, Michael G. Kauffman, Miguel Canales
Published 2021-07-01

Extracellular vesicle miRNA predict FDG‐PET status in patients with classical Hodgkin Lymphoma

by Esther E. E. Drees, Margaretha G. M. Roemer, Nils J. Groenewegen, Jennifer Perez‐Boza, Monique A. J. vanEijndhoven, Leah I. Prins, Sandra A. W. M. Verkuijlen, Xuan‐Mai Tran, Julia Driessen, G. J. C. Zwezerijnen, Phylicia Stathi, Kevin Mol, Joey J. J. P. Karregat, Aikaterini Kalantidou, Andrea Vallés‐Martí, T. J. Molenaar, Ernesto Aparicio‐Puerta, Erik vanDijk, Bauke Ylstra, Catharina G. M. Groothuis‐Oudshoorn, Michael Hackenberg, Daphne deJong, Josée M. Zijlstra, D. Michiel Pegtel
Published 2021-07-01